Dry Eye Syndrome Market Research Report Information By Type (Evaporative, and Aqueous), By Diagnosis (Schirmer Tets, and Eye Exam), By Treatment (Nutritional Supplement, and Surgery), By Distribution Channel (Hospital Pharmacies), By End User (Hospitals) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Dry Eye Syndrome Market, by Type

6.1 Introduction

6.2 Evaporative Dry Eye Syndrome

Market Estimates & Forecast, 2023 – 2030

6.3 Aqueous Dry Eye Syndrome

Market Estimates & Forecast, 2023 – 2030

Chapter 7. Global Dry Eye Syndrome Market, by Diagnosis

7.1 Introduction

7.2 Schirmer Test

Market Estimates & Forecast, 2023 – 2030

7.3 Eye Exam

Market Estimates & Forecast, 2023 – 2030

7.4 Others

Chapter 8. Global Dry Eye Syndrome Market, by Treatment

8.1 Introduction

8.2 Nutritional Supplements

Market Estimates & Forecast, 2023 – 2030

8.3 Serum Eye Drops

Market Estimates & Forecast, 2023 – 2030

8.4 Lubricant Eye Drops

Market Estimates & Forecast, 2023 – 2030

8.4.1 Oily Tear Eye Drops

8.4.2 Ointments

8.4.3 Preservative-Free drops

8.4.4 Others

8.5 Anti-Inflammatory Drugs Segments

Market Estimates & Forecast, 2023 – 2030

8.5.1 Tetracyclines

8.5.2 Corticosteroids

8.5.3 Others

8.6 Surgery

Market Estimates & Forecast, 2023 – 2030

8.6.1 Punctal Occlusion

8.6.2 Intense Pulsed Light Therapy

8.6.3 Others

8.7 Others

Chapter 9 Global Dry Eye Syndrome Market, by Distribution Channel

9.1 Introduction

9.2 Hospital pharmacies

Market Estimates & Forecast, 2023 – 2030

9.3 Retail pharmacies

Market Estimates & Forecast, 2023 – 2030

9.4 Online Pharmacies

Market Estimates & Forecast, 2023 – 2030

9.5 Others

Chapter 10 Global Dry Eye Syndrome Market, by End User

10.1 Introduction

10.2 Hospitals

Market Estimates & Forecast, 2023 – 2030

10.3 Clinics

Market Estimates & Forecast, 2023 – 2030

10.4 Home Care

Market Estimates & Forecast, 2023 – 2030

10.5 Others

Chapter 11. Global Dry Eye Syndrome Market, by Region

11.1 Introduction

11.2 America

11.2.1 North America

11.2.1.1 U.S.

11.2.1.2 Canada

11.2.2 South America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 U.K

11.3.1.6 Rest of Western Europe

11.3.2 Eastern Europe

11.4 Asia Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 Republic of Korea

11.4.6 Rest of Asia Pacific

11.5 The Middle East & Africa

11.5.1 United Arab Emirates

11.5.2 Saudi Arabia

11.5.3 Oman

11.5.4 Kuwait

11.5.5 Qatar

11.5.6 Rest of the The Middle East & Africa

Chapter 12 Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

12.3.1 Key Developments

Chapter 13 Company Profiles

13.1 Allergan

13.1.1 Company Overview

13.1.2 Product Overview

13.1.3 Financials

13.1.4 Key Developments

13.1.5 SWOT Analysis

13.2 Novartis AG

13.2.1 Company Overview

13.2.2 Product Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 Otsuka Pharmaceutical Co. Ltd.

13.3.1 Company Overview

13.3.2 Product Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Valent Pharmaceuticals

13.4.1 Company Overview

13.4.2 Product/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 Johnson and Johnson Vision

13.5.1 Company Overview

13.5.2 Product Overview

13.5.3 Financial overview

13.5.4 Key Developments

13.5.5 SWOT Analysis

13.6 Acadia Pharmaceutical

13.6.1 Company Overview

13.6.2 Product Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.6.5 SWOT Analysis

13.7 Allostera Pharma

13.7.1 Overview

13.7.2 Product Overview

13.7.3 Financials

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 I-Med Pharma Inc.

13.8.1 Overview

13.8.2 Product Overview

13.8.3 Financials

13.8.4 Key Developments

13.8.5 SWOT Analysis

13.9 Santen Pharmaceuticals Co. Ltd.

13.9.1 Overview

13.9.2 Product Overview

13.9.3 Financials

13.9.4 Key Developments

13.9.5 SWOT Analysis

13.10 AFT pharmaceuticals

13.10.1 Overview

13.10.2 Product Overview

13.10.3 Financials

13.10.4 Key Developments

13.10.5 SWOT Analysis

13.11 Novaliq GmBh

13.11.1 Overview

13.11.2 Product Overview

13.11.3 Financials

13.11.4 Key Developments

13.11.5 SWOT Analysis

13.12 Auven therapeutics

13.12.1 Overview

13.12.2 Product Overview

13.12.3 Financials

13.12.4 Key Developments

13.12.5 SWOT Analysis

13.13 Others

Chapter 14 MRFR Conclusion

14.1 Key Findings

14.1.1 From CEO’s View Point

14.1.2 Unmet Needs of the Market

14.2 Key Companies to Watch

14.3 Prediction of Dry Eye Syndrome Industry

Chapter 15 Appendix

LIST OF TABLES

Table 1 Dry Eye Syndrome Industry Synopsis, 2023 – 2030

Table 2 Global Dry Eye Syndrome Market Estimates and Forecast, 2023 – 2030, (USD Million)

Table 3 Global Dry Eye Syndrome Market by Region, 2023 – 2030, (USD Million)

Table 4 Global Dry Eye Syndrome Market by Type, 2023 – 2030, (USD Million)

Table 5 Global Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 6 Global Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 7 Global Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 8 Global Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

Table 9 North America Dry Eye Syndrome Market by Type, 2023 – 2030, (USD Million)

Table 10 North America Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 11 North America Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 12 North America Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 13 North America Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

Table 14 US Dry Eye Syndrome Market by Type, 2023 – 2030, (USD Million)

Table 15 US Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 16 US Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 17 US Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 18 US Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

Table 19 Canada Dry Eye Syndrome Market by Type, 2023 – 2030, (USD Million)

Table 20 Canada Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 21 Canada Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 22 Canada Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 23 Canada Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

Table 24 South America Dry Eye Syndrome Market by Type, 2023 – 2030, (USD Million)

Table 25 South America Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 26 South America Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 27 South America Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 28 South America Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

Table 29 Europe Dry Eye Syndrome Market by Type, 2023 – 2030, (USD Million)

Table 30 Europe Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 31 Europe Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 32 Europe Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 33 Europe Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

Table 34 Western Dry Eye Syndrome Europe Market by Type, 2023 – 2030, (USD Million)

Table 35 Western Europe Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 36 Western Europe Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 37 Western Europe Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 38 Western Europe Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

Table 39 Eastern Europe Dry Eye Syndrome Market by Type, 2023 – 2030, (USD Million)

Table 40 Eastern Europe Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 41 Eastern Europe Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 42 Eastern Europe Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 43 Eastern Europe Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

Table 44 Asia Pacific Dry Eye Syndrome Market by Type, 2023 – 2030, (USD Million)

Table 45 Asia Pacific Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 46 Asia Pacific Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 47 Asia Pacific Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 48 Asia Pacific Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

Table 49 The Middle East & Africa Dry Eye Syndrome Market by Type, 2023 – 2030, (USD Million)

Table 50 The Middle East & Africa Dry Eye Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)

Table 51 The Middle East & Africa Dry Eye Syndrome Market by Treatment, 2023 – 2030, (USD Million)

Table 52 The Middle East & Africa Dry Eye Syndrome Market by Distribution Channel, 2023 – 2030, (USD Million)

Table 53 The Middle East & Africa Dry Eye Syndrome Market by End User, 2023 – 2030, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Dry Eye Syndrome Market

Figure 3 Segmentation Market Dynamics for Global Dry Eye Syndrome Market

Figure 4 Global Dry Eye Syndrome Market Share, by Type 2023

Figure 5 Global Dry Eye Syndrome Market Share, by Diagnosis 2023

Figure 6 Global Dry Eye Syndrome Market Share, by Treatment 2023

Figure 7 Global Dry Eye Syndrome Market Share, by Distribution Channel 2023

Figure 8 Global Dry Eye Syndrome Market Share, by End User, 2023

Figure 9 Global Dry Eye Syndrome Market Share, by Region, 2023

Figure 10 North America Dry Eye Syndrome Market Share, by Country, 2023

Figure 11 Europe Dry Eye Syndrome Market Share, by Country, 2023

Figure 12 Asia Pacific Dry Eye Syndrome Market Share, by Country, 2023

Figure 13 The Middle East & Africa Dry Eye Syndrome Market Share, by Country, 2023

Figure 14 Global Dry Eye Syndrome Market: Company Share Analysis, 2023 (%)

Figure 15 Allergan: Key Financials

Figure 16 Allergan: Segmental Revenue

Figure 17 Allergan: Geographical Revenue

Figure 18 Novartis AG: Key Financials

Figure 19 Novartis AG: Segmental Revenue

Figure 20 Novartis AG: Geographical Revenue

Figure 21 Otsuka Pharmaceutical Co. Ltd.: Key Financials

Figure 22 Otsuka Pharmaceutical Co. Ltd.: Segmental Revenue

Figure 23 Otsuka Pharmaceutical Co. Ltd.: Geographical Revenue

Figure 24 Valent Pharmaceuticals: Key Financials

Figure 25 Valent Pharmaceuticals: Segmental Revenue

Figure 26 Valent Pharmaceuticals: Geographical Revenue

Figure 27 Johnson and Johnson Vision: Key Financials

Figure 28 Johnson and Johnson Vision: Segmental Revenue

Figure 29 Johnson and Johnson Vision: Geographical Revenue

Figure 30 Acadia Pharmaceutical: Key Financials

Figure 31 Acadia Pharmaceutical: Segmental Revenue

Figure 32 Acadia Pharmaceutical: Geographical Revenue

Figure 33 Allostera Pharma: Key Financials

Figure 34 Allostera Pharma: Segmental Revenue

Figure 35 Allostera Pharma: Geographical Revenue

Figure 36 I-Med Pharma Inc.: Key Financials

Figure 37 I-Med Pharma Inc.: Segmental Revenue

Figure 38 I-Med Pharma Inc.: Geographical Revenue

Figure 39 Santen Pharmaceuticals Co. Ltd.: Key Financials

Figure 40 Santen Pharmaceuticals Co. Ltd.: Segmental Revenue

Figure 41 Santen Pharmaceuticals Co. Ltd.: Geographical Revenue

Figure 42 AFT pharmaceuticals: Key Financials

Figure 43 AFT pharmaceuticals: Segmental Revenue

Figure 44 AFT pharmaceuticals: Geographical Revenue

Figure 45 Novaliq GmBh: Key Financials

Figure 46 Novaliq GmBh: Segmental Revenue

Figure 47 Novaliq GmBh: Geographical Revenue

Figure 48 Auven therapeutics: Key Financials

Figure 49 Auven therapeutics: Segmental Revenue

Figure 50 Auven therapeutics: Geographical Revenue